Patrick Kanda

1.9k citations
46 papers · 1.7k indexed · h-index 22

Patrick Kanda

45 papers receiving 1.6k citations

Peers

Patrick Kanda
Comparison fields: 5 of 80
  • Virology 576
  • Immunology 457
  • Molecular Biology 915
  • Infectious Diseases 241
  • Radiology, Nuclear Medicine and Imaging 251
Replace Alan M. Schultz with:
Alan M. Schultz United States
Gary W. Smythers United States
Hanno V.J. Kolbe France
Jon W. Marsh United States
Tajib A. Mirzabekov United States
Nava Sarver United States
Ira Palmer United States
J A Griffin United States
Jaisri R. Lingappa United States
Bruno Beaumelle France
Patrick Kanda relative to Alan M. Schultz United States Alan M. Schultz's profile →
Citations per field
00.5×
Alan M. Schultz · 1×
Citations per year

Countries citing papers authored by Patrick Kanda

Since Specialization
Citations

This map shows the geographic impact of Patrick Kanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Kanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Kanda more than expected).

Fields of papers citing papers by Patrick Kanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Kanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Kanda. The network helps show where Patrick Kanda may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Patrick Kanda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick Kanda Line = papers co-authored together Patrick Kanda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20202
2 20178
3 201512
4 199717
5 19954
6 19938
7 199222
8 199232
9 19929
10 199131
11 199121
12 199126
13 199048
14 199015
15 199036
16 198832
17 198843
18 1988107
19 198862
20 198720

About Patrick Kanda

Patrick Kanda is a scholar working on Virology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 46 papers that have together received 1.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (18 papers), Immune Cell Function and Interaction (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), HIV/AIDS drug development and treatment (7 papers), T-cell and B-cell Immunology (7 papers), T-cell and Retrovirus Studies (6 papers), Glycosylation and Glycoproteins Research (5 papers) and Chemical Synthesis and Analysis (5 papers). The work is most often cited by research in Virology (576 citations), Immunology (457 citations) and Molecular Biology (915 citations). Patrick Kanda has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Ronald C. Kennedy, Robert E. Lanford, Tran C. Chanh, Lili Yamasaki, James T. Sparrow, R C Kennedy, David D. Ho, Gordon R. Dreesman, Gerald P. Linette and M A Wells. Their work appears in journals such as Molecular Immunology, Journal of Lipid Research, Molecular and Cellular Biology, Virology and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026